Tag Archive for: Women’s health

BII & Science launch the Translational Medicine Prize for Innovations in Women´s Health and Gender Medicine

/in

BioInnovation Institute (BII), an international non-profit foundation, incubating and accelerating world-class life science research, today announces the launch of the BII & Science Translational Medicine Prize for Innovations in Women´s Health and Gender Medicine. This follows the successful BII & Science Prize for Innovation – which is now in its third year and recognizes and celebrates bold researchers internationally […]

Read more

BII welcomes twelve new companies to its Venture Lab program

/in

BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, today announces that twelve new companies have entered its Venture Lab acceleration program for early-stage companies. The cohort is strategically aligned with BII’s focus on supporting innovative early-stage start-ups that can improve human and planetary health. Read more…

Read more

Versameb Announces FDA Clearance of IND Application for VMB-100 in the Treatment of Stress Urinary Incontinence

/in

Versameb AG (“Versameb”), a pre-clinical stage company focused on transforming RNA therapeutics to treat unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application of VMB-100, a potency enhanced messenger ribonucleic acid (mRNA) encoding human insulin-like growth factor-1 (IGF-1), for the treatment of stress […]

Read more

Oxolife Appoints International Fertility Experts to its Scientific Advisory Board

/in

Leading experts in fertility and human reproduction with more than 1,200 fertility and reproduction-related publications SAB involved in the clinical management at top global reproductive clinics and research centers worldwide Support plans to advance clinical development of OXO-001, a novel first in class treatment for infertility Barcelona, Spain – 13th November 2023, Oxolife, the specialist […]

Read more

Futura Medical Announces Agreement With Haleon To Commercialise MED3000 In The USA

/in

Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology, focused on sexual health, today announces that it has entered into a ground breaking licensing agreement with Haleon plc (“Haleon”), a world leading consumer healthcare Company for the rights to […]

Read more